| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 07/30/1996 | US5541289 Reducing a phosphine sulfide to a phosphine in a peptide |
| 07/30/1996 | US5541287 Diagnosis using cyclic tripeptides with nitrobenzyl 1,4,7,10-tetraazacyclododecane-n,n*,n**,n***tetraacetic acid biotin conjugate formed by alkylation and multistage process |
| 07/30/1996 | US5541255 Having improved resolution of small biomolecules |
| 07/30/1996 | US5541159 Calcitonin derivatives |
| 07/30/1996 | US5541061 Methods for screening factorial chemical libraries |
| 07/30/1996 | US5540923 Antiviral, antitumor, from trophoblast cells |
| 07/30/1996 | CA1338502C Solid support chemistry system |
| 07/30/1996 | CA1338500C Glycosylated amino acids and peptides |
| 07/25/1996 | WO1996022304A1 Conformationally constrained reverse-turn library and methods relating thereto |
| 07/25/1996 | WO1996022157A1 Apparatus and method for multiple synthesis of organic compounds on polymer support |
| 07/25/1996 | WO1996022067A2 Peptide ratchet libraries for ctl-inducing vaccines and therapeutics |
| 07/25/1996 | CA2211029A1 Apparatus and method for multiple synthesis of organic compounds on polymer support |
| 07/25/1996 | CA2210349A1 Conformationally constrained reverse-turn library and methods relating thereto |
| 07/24/1996 | EP0723015A1 Novel modified PF4 compositions and methods of use |
| 07/24/1996 | EP0723013A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/24/1996 | EP0722951A2 Method and apparatus for the production of TGF-beta and purified TGF-beta compositions |
| 07/24/1996 | EP0722735A1 Parathyroid hypertensive factor |
| 07/24/1996 | EP0722492A1 Stabilisation of proteins in solution |
| 07/24/1996 | EP0722458A1 Peralkylated oligopeptide mixtures |
| 07/24/1996 | EP0722457A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 07/24/1996 | EP0722456A1 Antifungal compositions |
| 07/24/1996 | EP0722329A1 Alpha 1?-acid glycoprotein purification process and product |
| 07/24/1996 | EP0665850A4 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions. |
| 07/24/1996 | EP0560968B1 Vaccine for neisseria meningitidis infections |
| 07/24/1996 | EP0555336B1 Homobifunctional agents for coupling enzymes and the like to antibodies and the like |
| 07/24/1996 | CN1127509A New peptide derivatives |
| 07/24/1996 | CN1127260A Purification process for hirudin using affinity chromatography |
| 07/24/1996 | CA2167763A1 Mercaptoalkyldipeptide derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 07/23/1996 | US5539087 Antibiotic A/16686 recovery process |
| 07/23/1996 | US5539086 Therapeutic fragments of von Willebrand factor |
| 07/23/1996 | US5539084 Separation of a specific binding entity for a mixture |
| 07/23/1996 | US5539083 Peptide nucleic acid combinatorial libraries and improved methods of synthesis |
| 07/23/1996 | US5539063 Polymer for making poly(ethylene glycol)-protein conjugates |
| 07/23/1996 | US5538950 Endothelin antagonists and their preparation |
| 07/23/1996 | US5538946 Hirudin derivatives with delayed action |
| 07/23/1996 | US5538897 Use of mass spectrometry fragmentation patterns of peptides to identify amino acid sequences in databases |
| 07/23/1996 | US5538853 Antibody polypeptides for detection by binding and labels |
| 07/23/1996 | US5538844 Transport protein gene from the Huntington's disease region |
| 07/23/1996 | US5538694 Device for simultaneously or sequentially carrying out chemical reactions |
| 07/18/1996 | WO1996021464A1 Compositions for the delivery of antigens |
| 07/18/1996 | WO1996012168A3 A rapidly convergent method for Boltzmann-weighted ensemble generation in free energy simulations |
| 07/18/1996 | WO1996006860A3 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 07/18/1996 | DE19500932A1 Specific incorporation of unnatural amino acid into protein in vivo |
| 07/18/1996 | CA2209492A1 Compositions for the delivery of antigens |
| 07/17/1996 | EP0721983A1 Methods of producing biologically active peptide dimers |
| 07/17/1996 | EP0721449A1 INHIBITORS OF $g(b)-AMYLOID PROTEIN PRODUCTION |
| 07/17/1996 | EP0528822B1 A co-hydrolytic process for the production of novel extracts from yeast and non-yeast proteins |
| 07/17/1996 | EP0441900B1 Natural killer stimulatory factor |
| 07/17/1996 | CN1032315C Method for producing hepatitis B virus proteins in yeast |
| 07/16/1996 | US5536816 Process for producing amides using catalytic amounts of an N-hydroxy compound |
| 07/16/1996 | US5536815 Cyclopropyl based O- and N- and S-protecting groups |
| 07/16/1996 | CA2034489C Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 07/11/1996 | WO1996020955A1 Purified thrombopoietin and method of making it |
| 07/11/1996 | WO1996020724A1 Generation of human insulin |
| 07/11/1996 | CA2207577A1 Purified thrombopoietin and method of making it |
| 07/10/1996 | EP0720988A1 Pseudopeptides containing trifluoromethyl substituted 2-azabicyclooctane |
| 07/10/1996 | EP0720987A1 Acylated pseudopeptides containing trifluoromethyl substituted 2-azabicyclooctane |
| 07/10/1996 | EP0720620A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 07/10/1996 | EP0720618A1 Process for the purification of basic fibroblast growth factor |
| 07/10/1996 | EP0720482A1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 07/10/1996 | EP0546055B1 Polyethylene glycol derivatives for solid-phase applications |
| 07/10/1996 | EP0370090B1 Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens |
| 07/10/1996 | CN1126477A Separation of proteins |
| 07/10/1996 | CN1126441A Amplification of the vitamin B12 uptake system using polymers |
| 07/10/1996 | CN1126436A Vitamin B12 mediated oral delivery systems for GCSF and EPO |
| 07/09/1996 | US5534621 Immunoaffinity purification methods using single polypeptide chain binding molecules |
| 07/09/1996 | US5534498 Trypsin inhibitors |
| 07/09/1996 | US5534414 Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein |
| 07/09/1996 | CA1338453C Purified protein having angiogenic activity and methods of preparation |
| 07/05/1996 | CA2166374A1 Acylated pseudopeptides containing a trifluoromethyl-substituted 2-azabicyclooctane |
| 07/05/1996 | CA2166372A1 Pseudopeptides having a trifluoromethyl-substituted 2-azabicyclooctane |
| 07/04/1996 | WO1996020403A1 Assay, receptor proteins and ligands |
| 07/04/1996 | WO1996020278A2 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| 07/04/1996 | WO1996020211A1 Phosphotyrosine assay and peptides for use therein |
| 07/04/1996 | WO1996020012A2 Methods for preparing and purifying macromolecular conjugates |
| 07/04/1996 | WO1996020002A1 Immobilization of peptides to hyaluronate |
| 07/04/1996 | WO1996019999A1 Thrombolytic enzyme and method of obtaining same |
| 07/04/1996 | CA2228723A1 Assay, receptor proteins and ligands |
| 07/04/1996 | CA2208319A1 Assay, receptor proteins and ligands |
| 07/04/1996 | CA2208318A1 Phosphotyrosine assay and peptides for use therein |
| 07/04/1996 | CA2207820A1 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| 07/03/1996 | EP0719860A1 Compositions and method for treating or preventing infections in animals |
| 07/03/1996 | EP0719792A2 Somatotropin variants |
| 07/03/1996 | EP0719789A1 Process of producing alpha-L-aspartyldipeptide amide derivatives |
| 07/03/1996 | EP0719283A1 Factor for fibroblast colony forming unit |
| 07/03/1996 | EP0719279A1 Process for purifying 1- n(2 -((s)-ethoxycarbonyl)-3-phenylpropyl)-n6 -trifluoroacetyl]-l-lysyl-l-prolin (lisinopril(tfa)ethylester) |
| 07/03/1996 | EP0579785B1 Substituted benzhydrylamines as handles for solid phase peptide synthesis |
| 07/03/1996 | EP0249613B1 Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4) |
| 07/03/1996 | CN1125952A Process for manufacture of 1-deamino-8-D-arginine vasopressin |
| 07/02/1996 | US5532407 Adding l-aspartic acid or aqueous solution to side stream from production of alpha-l-aspartyl-l-phenylalanine methyl ester before or after mineral acid hydrolysis of side stream, adjusting ph of hydrolysis reaction mixture to 5-6 |
| 07/02/1996 | US5532366 Enzyme inhibitors |
| 07/02/1996 | US5532352 Chemically modifying hemoglobin for use in a blood substitute |
| 07/02/1996 | US5532343 Purification and characterization of a glioma-derived growth factor having vascular endothelial cell growth promoting activity |
| 07/02/1996 | US5532341 Polypeptides for stimulating growth of bone marrow cells |
| 07/02/1996 | US5532214 Anti-HIV protein, TAP 29, from tricosanthes, DNA coding therefor and therapeutic uses thereof |
| 07/02/1996 | US5532169 Quantitating concentration of peptides in body fluids and collagen telopeptides with hydroxylysyl pyridoline crosslinking |
| 07/02/1996 | US5532167 Polypeptides for phosphorylation of substrate protein kinase orientation and degeneration, separation by binding to ferric columns, detection of sequences |
| 07/02/1996 | US5532159 Antitumor agents; hybridomas |
| 07/02/1996 | US5532015 Drying wet crystals of l-aspartyl-l-phenylalanine methyl ester to adjust the water content |
| 07/02/1996 | US5531185 Manufacturing apparatus for use in a micro-gravity environment |